Skip to content

Stem Cell and Regenerative Therapy Regulation Advisory Group.

This bill failed and is no longer moving.

CA AB 617 · Assembly Bill · 2019–2020

Stage
Failed
Started in
Assembly
Sponsor
1
Latest action
Feb 3, 2020

What it does

Existing law, including, among other laws, the Medical Practice Act, the Osteopathic Act, and the Nursing Practice Act, provides for the licensure and regulation of various health care practitioners by various boards within the Department of Consumer Affairs, including the Medical Board of California, the Osteopathic Medical Board of California, and the Board of Registered Nursing. Existing law requires licensed health care practitioners who perform stem cell therapies that are subject to regulation by the United States Food and Drug Administration (FDA) , but are not FDA approved, to communicate to their patients specified information regarding the therapies in a notice and in writing…

Read the full text

Where it stands

This bill failed and is no longer moving.

Failed

This bill failed and is no longer moving.

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

Once a bill is decided, the questions are about what is done with it in California.

Work with this bill

Stem Cell and Regenerative Therapy Regulation Advisory Group. | 52